These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37612282)

  • 21. K235 acetylation couples with PSPC1 to regulate the m
    Zhang XL; Chen XH; Xu B; Chen M; Zhu S; Meng N; Wang JZ; Zhu H; Chen D; Liu JB; Yan GR
    Nat Commun; 2023 Jun; 14(1):3815. PubMed ID: 37369679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
    Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
    Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
    Yang Z; Cai Z; Yang C; Luo Z; Bao X
    EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways.
    Qu J; Hou Y; Chen Q; Chen J; Li Y; Zhang E; Gu H; Xu R; Liu Y; Cao W; Zhang J; Cao L; He J; Cai Z
    Oncogene; 2022 Jan; 41(3):400-413. PubMed ID: 34759347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. m
    Tang B; Yang Y; Kang M; Wang Y; Wang Y; Bi Y; He S; Shimamoto F
    Mol Cancer; 2020 Jan; 19(1):3. PubMed ID: 31906946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma.
    Lv D; Zhong C; Dixit D; Yang K; Wu Q; Godugu B; Prager BC; Zhao G; Wang X; Xie Q; Bao S; He C; Heiland DH; Rosenfeld MG; Rich JN
    Mol Cell; 2023 Dec; 83(23):4334-4351.e7. PubMed ID: 37979586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALKBH5 controls the meiosis-coupled mRNA clearance in oocytes by removing the N 
    Bai L; Xiang Y; Tang M; Liu S; Chen Q; Chen Q; Zhang M; Wan S; Sang Y; Li Q; Wang S; Li Z; Song Y; Hu X; Mao L; Feng G; Cui L; Ye Y; Zhu Y
    Nat Commun; 2023 Oct; 14(1):6532. PubMed ID: 37848452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
    Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
    Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N
    Zhu Z; Qian Q; Zhao X; Ma L; Chen P
    Gene; 2020 Mar; 731():144348. PubMed ID: 31927006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of
    Li XC; Jin F; Wang BY; Yin XJ; Hong W; Tian FJ
    Theranostics; 2019; 9(13):3853-3865. PubMed ID: 31281518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulated ALKBH5 contributes to myocardial ischemia/reperfusion injury by increasing m
    Li J; Chen J; Zhao M; Li Z; Liu N; Fang H; Fang M; Zhu P; Lei L; Chen C
    Ann Transl Med; 2022 Apr; 10(7):417. PubMed ID: 35530959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALKBH5-mediated m
    Chen Y; Zhou P; Deng Y; Cai X; Sun M; Sun Y; Wu D
    Clin Transl Med; 2023 Feb; 13(2):e1198. PubMed ID: 36792369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m
    Yu T; Yao L; Yin H; Teng Y; Hong M; Wu Q
    Int J Biol Sci; 2022; 18(6):2235-2248. PubMed ID: 35414790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoting axon regeneration by inhibiting RNA N6-methyladenosine demethylase ALKBH5.
    Wang D; Zheng T; Zhou S; Liu M; Liu Y; Gu X; Mao S; Yu B
    Elife; 2023 Aug; 12():. PubMed ID: 37535403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the Demethylase AlkB Homolog H5 in the Promotion of Dentinogenesis.
    Tian C; Chai J; Liu W; Zhang X; Li Y; Zuo H; Yuan G; Zhang H; Liu H; Chen Z
    Front Physiol; 2022; 13():923185. PubMed ID: 35784864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RBM33 is a unique m
    Yu F; Zhu AC; Liu S; Gao B; Wang Y; Khudaverdyan N; Yu C; Wu Q; Jiang Y; Song J; Jin L; He C; Qian Z
    Mol Cell; 2023 Jun; 83(12):2003-2019.e6. PubMed ID: 37257451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALKBH5 suppresses tumor progression via an m
    Yuan Y; Yan G; He M; Lei H; Li L; Wang Y; He X; Li G; Wang Q; Gao Y; Qu Z; Mei Z; Shen Z; Pu J; Wang A; Zhao W; Jiang H; Du W; Yang L
    Cell Death Dis; 2021 Jan; 12(1):60. PubMed ID: 33431791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.
    Gong H; Liu L; Cui L; Ma H; Shen L
    Mol Carcinog; 2021 Sep; 60(9):644-657. PubMed ID: 34169564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.